WERFEN
LIVE

Serial Number

97495357

Owner

WERFENLIFE S.A.

Attorney

Deborah J. Peckham

First Use Date

Jan 1, 2007

Filing Date

Jul 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

WERFEN Trademark

Serial Number: 97495357 • Registration: 7424568

WERFEN is a trademark filed by WERFENLIFE S.A. on July 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

WERFENLIFE S.A. (2 trademarks)

Plaça d'Europa 21-23
Barcelona 08908 , ES

Entity Type: 85

WERFEN S.A. (3 trademarks)

Plaça d'Europa 21-23

Entity Type: 03

Trademark Details

Filing Date

July 8, 2022

Registration Date

June 25, 2024

First Use Anywhere

January 1, 2007

First Use in Commerce

January 1, 2007

Published for Opposition

April 9, 2024

Goods & Services

Installation of medical apparatus; Maintenance of medical apparatus; Maintenance of medical devices; Maintenance of medical instruments; Medical apparatus repair

Warehousing; Distribution services, namely, delivery of products, devices and instruments for in vitro diagnostics, and medical devices embedded with clinical data computer applications and software for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Import and export services, namely, transportation of the merchandise of others in the nature of products, apparatus and instruments for in vitro analysis and diagnosis, diagnostic kits consisting of sample receivers and reagents for analyzing selected bacteria, biomolecular labeling kits consisting of reagents for use in scientific research, mixtures of chemical reagents in kit form, other than those for medical or veterinary use, mixtures of chemical reagents, other than for medical or veterinary use, analytical reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for medical laboratory use, diagnostic reagents for scientific or research use, test reagents, other than those for medical use, test reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis other than for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for use in in vitro laboratories for medical or veterinary purposes, chemical reagents for medical or veterinary tests, medical devices embedded with software and computer programs for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Transportation of products, devices and instruments for in vitro diagnostics and laboratory information systems, and medical devices embedded with software and computer applications for data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, such as therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation by domestic transportation means

Clinical medical reagents; Diagnostic reagents for medicinal use; Immunoassay reagents for medical use; Chemical reagents for medical or veterinary purposes; Medical diagnostic reagents; Veterinary diagnostic reagents

Computers; Apparatus for broadcasting, recording, transmission or reproduction of sound or images; Data processing equipment; Recorded computer programs for database management for laboratory information systems, data management for specific clinical applications, data analysis for integrated communication solutions, data analysis for clinical diagnostics, data analysis for comprehensive solutions for patient-focused systems, clinical diagnosis and evaluation for therapy management, clinical diagnosis and evaluation for chronic disorders, and clinical diagnosis and evaluation for telemedicine

Engineering services, namely, engineering for the research, design and development of products, devices and instruments for in vitro diagnostics, computer applications and software for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Installation of computer software; Maintenance of computer software; Repair of software; Scientific and technological services, namely, scientific research, design and development of in vitro diagnostic devices and instruments, computer applications and software for laboratory information systems, data management for specific clinical applications, integrated communication solutions, clinical diagnostic and patient-focused systems, such as therapy management, chronic disorders and telemedicine, medical-surgical devices and instruments for the hospital sector, scientific, analytical and laboratory instrumentation in the field of health technologies

Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated coagulation analyzers, namely, electronic instruments for measuring the characteristics and components of blood clots; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated bodily fluid analyzers, namely, automated instruments for measuring blood gases, hematocrit, hemoglobin, and electrolytes; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of disposable cartridges containing reagents for diagnostic testing of bodily fluids in an automated bodily fluid analyzer; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automatic clinical analyzers, namely, electronic instruments for measuring the partial pressure of oxygen and carbon dioxide and ionic activity in the blood

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2025 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 28, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 28, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
EXPARTE APPEAL TERMINATED
Mar 6, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 5, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 29, 2024 CRFA
ASSIGNED TO LIE
Feb 29, 2024 ALIE
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 10, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Oct 10, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 10, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 10, 2023 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 7, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 7, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 10, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 10, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 10, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 16, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2022 DOCK
ASSIGNED TO EXAMINER
Sep 16, 2022 DOCK
PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
Sep 16, 2022 PMSG
PETITION TO DIRECTOR - MAKE SPECIAL - DENIED
Aug 24, 2022 PMSD
ASSIGNED TO PETITION STAFF
Aug 22, 2022 APET
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2022 NWOS
TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Jul 19, 2022 TPMS
NEW APPLICATION ENTERED
Jul 12, 2022 NWAP